GFI1B and acute myeloid leukemia: Given that our observation of upregulated OXPHOS and FAO was made in Gfi1b-deficient AML cells, we tested the therapeutic effects of venetoclax and FAO inhibitors on the proliferation of AML cells with low-level Gfi1b.